Market Insights Health OTC Pharmaceuticals

Analgesics - Mauritius

Mauritius

In Mauritius, the revenue in the Analgesics market reaches US$8.07 in 2024.
It is projected that the market will experience an annual growth rate of 7.38% (CAGR 2024-2029).
Comparatively, the in the United States generates the highest revenue in the global market, amounting to US$7,243.00 in 2024.
When considering the total population, the per person revenue in Mauritius amounts to US$6.20 in 2024.
Despite the small size of the market, Mauritius has seen a growing demand for analgesics due to the increasing prevalence of chronic pain conditions among its population.

Key regions: Brazil, Europe, Germany, Canada, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in Mauritius has been experiencing steady growth in recent years, driven by customer preferences for over-the-counter pain relief products, evolving market trends, and local special circumstances. Customer preferences in Mauritius have been shifting towards self-medication and the use of over-the-counter analgesics. This can be attributed to the convenience and accessibility of these products, as well as the increasing awareness among consumers about the benefits of self-care. Additionally, the rising healthcare costs and long waiting times for doctor appointments have also contributed to the preference for self-medication. In terms of market trends, there has been a growing demand for natural and herbal analgesics in Mauritius. Consumers are becoming more health-conscious and are seeking products that are perceived to be safer and have fewer side effects. This trend is in line with the global shift towards natural and organic products. Manufacturers in the analgesics market have responded to this trend by introducing a wide range of natural and herbal pain relief products to cater to the evolving preferences of consumers in Mauritius. Another trend in the market is the increasing use of online platforms for purchasing analgesics. E-commerce has gained significant popularity in Mauritius, with consumers opting for the convenience of online shopping. This trend has been further accelerated by the COVID-19 pandemic, which has resulted in increased reliance on online channels for purchasing essential goods. As a result, pharmaceutical companies and retailers have been investing in online platforms and home delivery services to cater to the growing demand for analgesics in Mauritius. In addition to customer preferences and market trends, there are also local special circumstances that have influenced the development of the analgesics market in Mauritius. One such circumstance is the high prevalence of chronic diseases, such as arthritis and migraines, which require long-term pain management. This has created a consistent demand for analgesics in the country. Furthermore, the aging population in Mauritius has also contributed to the growth of the market, as older adults are more likely to experience chronic pain and require regular pain relief medication. Underlying macroeconomic factors, such as the overall economic growth and disposable income levels in Mauritius, have also played a role in the development of the analgesics market. As the economy continues to grow, consumers have more purchasing power, which allows them to afford and prioritize healthcare products, including analgesics. Additionally, the government's efforts to improve healthcare infrastructure and services have also contributed to the growth of the market, as it has increased access to healthcare and pharmaceutical products for the population. Overall, the Analgesics market in Mauritius is experiencing growth due to customer preferences for over-the-counter products, evolving market trends towards natural and online shopping, local special circumstances such as the prevalence of chronic diseases, and underlying macroeconomic factors such as economic growth and improved healthcare infrastructure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.